Carcinologic Speech Severity Index

The hypothesis of the present study is that an automatic assessment technic can measure the impact of the speech disorders on the communication abilities giving a severity index of speech in patients treated for head and neck and particularly for oral and pharyngeal cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Head and Neck Cancer Head and Neck Neoplasms Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Oral and Pharyngeal cancer T2 to T4 for having a wide dynamic of deficit
Treatment by surgery and/or radiotherapy and/or chemotherapy
Delay after the end of the treatment of minimum 6 months.

Exclusion criteria

Patients with a previous speech disorders (ie stuttering… )
Patients not able to perform the whole task

Treatment and study plan

automatic speech processing tool

Procedure

Primary outcomes

carcinologic speech severity index

Time frame: day 0

The main objective is to demonstrate that the carcinologic speech severity index (C2SI), obtained by an automatic speech processing tool, produces equivalent or superior outcomes than a score of speech intelligibility obtained by human listeners, in terms of quality of life foreseeing the speech handicap, after the treatment of oral and/or pharyngeal cancer.

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Collaborators

University Jean-Jaures, Toulouse, France

Registry information

Official study title

A Speech Disorders Severity Index to Measure the Impact of Oral and Pharyngeal Cavity on Speech Production

Acronym: C2SI

Important dates

Study start: 2015
Primary completion: 2017
Study completion: 2017
First posted: Aug 23, 2016
Registry last updated: Jul 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed